Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, G1 Therapeutics Inc (NASDAQ: GTHX) closed at $3.75 down -4.09% from its previous closing price of $3.91. In other words, the price has decreased by -$4.09 from its previous closing price. On the day, 1.18 million shares were traded. GTHX stock price reached its highest trading level at $3.98 during the session, while it also had its lowest trading level at $3.53.
Ratios:
For a deeper understanding of G1 Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.55 and its Current Ratio is at 2.94. In the meantime, Its Debt-to-Equity ratio is 1.70 whereas as Long-Term Debt/Eq ratio is at 1.48.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 30, 2023, Upgraded its rating to Neutral and sets its target price to $10 from $7 previously.
On January 03, 2023, Needham reiterated its Buy rating and also upped its target price recommendation from $32 to $31.
JP Morgan Downgraded its Neutral to Underweight on November 04, 2021, whereas the target price for the stock was revised from $20 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 05 ’24 when Bailey John E. (Jack) Jr. sold 7,662 shares for $2.51 per share. The transaction valued at 19,214 led to the insider holds 549,674 shares of the business.
Avagliano Mark sold 2,638 shares of GTHX for $6,615 on Jul 05 ’24. The Chief Business Officer now owns 242,045 shares after completing the transaction at $2.51 per share. On Jul 05 ’24, another insider, MURDOCK TERRY L, who serves as the Chief Operating Officer of the company, sold 2,475 shares for $2.51 each. As a result, the insider received 6,207 and left with 128,012 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GTHX now has a Market Capitalization of 196055248 and an Enterprise Value of 177958224. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.33 while its Price-to-Book (P/B) ratio in mrq is 7.06. Its current Enterprise Value per Revenue stands at 2.118 whereas that against EBITDA is -7.97.
Stock Price History:
Over the past 52 weeks, GTHX has reached a high of $6.14, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 16.24%, while the 200-Day Moving Average is calculated to be 19.98%.
Shares Statistics:
For the past three months, GTHX has traded an average of 1.59M shares per day and 890980 over the past ten days. A total of 51.93M shares are outstanding, with a floating share count of 42.75M. Insiders hold about 18.23% of the company’s shares, while institutions hold 27.84% stake in the company. Shares short for GTHX as of 1721001600 were 7034857 with a Short Ratio of 4.43, compared to 1718323200 on 4894345. Therefore, it implies a Short% of Shares Outstanding of 7034857 and a Short% of Float of 13.58.
